Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study
NCT02195505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 374
Last updated 2014-07-21
Summary
The USAGE study aims at assessing on a long-term period (two years in average) the outcome in clinical or economical term of patients with knee osteoarthritis (OA) treated or not with Synvisc®, in the 1139.4 clinical trial.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-30
- Primary Completion
- 2002-04-30
More Related Trials
-
An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint
NCT06485843 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee
NCT00131352 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment
NCT02389452 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study
NCT00198029 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis
NCT00131300 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Efficacy Civamide in Osteoarthritis (OA) of the Knee(s)
NCT00995306 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Intra-articular Hyaluronic Acid in the Knee Osteoarthritis
NCT00556608 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee
NCT00653432 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis
NCT00131768 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee
NCT04369261 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee
NCT05337540 ·Status: COMPLETED ·Phase: NA
-
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
NCT00689273 ·Status: COMPLETED ·Phase: PHASE2
-
BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis
NCT02230956 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis
NCT03595618 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee
NCT00379236 ·Status: COMPLETED ·Phase: NA
-
Synovial Fluid Biomarkers Pre and Post Hymovis Knee Injection
NCT04093232 ·Status: UNKNOWN
-
Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis
NCT01425853 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA
NCT05237752 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
NCT02536833 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis
NCT02951026 ·Status: COMPLETED
-
Sinomenine Versus Glucocorticoid for Knee OA
NCT05764304 ·Status: UNKNOWN ·Phase: PHASE3
-
The Efficacy of Viscosupplementation for Early Knee Osteoarthritis
NCT01210742 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip
NCT01618708 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)
NCT00296569 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Hymovis ONE® (32mg/4ml) Intrarticular Injection in Active Patients With Knee Overuse Syndrome
NCT04661111 ·Status: COMPLETED ·Phase: NA